Cargando…

Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis

Hepatocellular carcinoma (HCC) is one of the leading contributors to cancer mortality worldwide and is a leading cause of death in individuals with chronic hepatitis B virus (HBV) infection. It is uncertain how the presence of other metabolic factors and comorbidities influences HCC risk in HBV. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Cori, Wang, Tingyan, McNaughton, Anna L., Barnes, Eleanor, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581992/ https://www.ncbi.nlm.nih.gov/pubmed/33305479 http://dx.doi.org/10.1111/jvh.13452

Ejemplares similares

Estimating the epidemiology of chronic Hepatitis B Virus (HBV) infection in the UK: what do we know and what are we missing?
por: Campbell, Cori, et al.
Publicado: (2023)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Case Report: Application of hepatitis B virus (HBV) deep sequencing to distinguish between acute and chronic infection
por: Downs, Louise O., et al.
Publicado: (2021)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)
por: McNaughton, Anna L., et al.
Publicado: (2019)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
por: Sartorius, Kurt, et al.
Publicado: (2019)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
por: Downs, Louise O., et al.
Publicado: (2023)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts
por: Brown, Robin, et al.
Publicado: (2022)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
por: Sartorius, Kurt, et al.
Publicado: (2020)

Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?
por: Pley, Caitlin, et al.
Publicado: (2022)

Polymorphisms predicting phylogeny in hepatitis B virus
por: Lourenço, José, et al.
Publicado: (2022)

FAIR data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect
por: Matthews, Philippa C
Publicado: (2019)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

Serum Iron Levels Decreased in Patients with HBV-Related Hepatocellular Carcinoma, as a Risk Factor for the Prognosis of HBV-Related HCC
por: Wei, Yanyan, et al.
Publicado: (2018)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma
por: Petruzziello, Arnolfo
Publicado: (2018)

Hepatitis B Virus Adaptation to the CD8+ T Cell Response: Consequences for Host and Pathogen
por: Lumley, Sheila F., et al.
Publicado: (2018)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma
por: Li, Cong, et al.
Publicado: (2014)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Insights From Deep Sequencing of the HBV Genome—Unique, Tiny, and Misunderstood
por: McNaughton, Anna L., et al.
Publicado: (2019)

The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Cohort Profile: The National Institute for Health Research Health Informatics Collaborative: Hepatitis B Virus (NIHR HIC HBV) research dataset
por: Wang, Tingyan, et al.
Publicado: (2022)

Comparison between using hepatocellular carcinoma (HCC) risk scores and the HCC national guideline to identify high‐risk chronic hepatitis B patients for HCC surveillance in Thailand
por: Rattananukrom, Chitchai, et al.
Publicado: (2022)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65494ndrs50cvkrks8jg0ji75d